Etonogestrel

規格

54048-10-1CAS番号

258-936-2EC番号

(8S,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-11-methylidene-2,6,7,8,9,10,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-oneIUPAC名

C22H28O2化学式

324.5 g/mol分子量

ETONOGESTREL; 54048-10-1; Implanon; 3-Oxodesogestrel; 3-Ketodesogestrel; nexplanon; 3-Keto-desogestrel; Org-3236; etonogestrelum; ORG 3236; DTXSID9046782; (8S,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-11-methylidene-2,6,7,8,9,10,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one; 304GTH6RNH; 13-Ethyl-17-hydroxy-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one; DTXCID7026782; CHEBI:50777; (17-alpha)-13-Ethyl-17-hydroxy-11-methylene-18,19-dinorpregn-4-en-20-yn-3-one; 18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-11-methylene-, (17-alpha)-; 18,19-Dinor-17alpha-pregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-11-methylene-; 3-oxo desogestrel; (1S,2R,10S,11S,14R,15S)-15-ethyl-14-ethynyl-14-hydroxy-17-methylidenetetracyclo(8.7.0.0^(2,7).0^(11,15))heptadec-6-en-5-one; (1S,2R,10S,11S,14R,15S)-15-ethyl-14-ethynyl-14-hydroxy-17-methylidenetetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one; (8S,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-11-methylidene-2,6,7,8,9,10,12,14,15,16-decahydro-1H-cyclopenta(a)phenanthren-3-one; RefChem:56821; G03AC08; MFCD00867863; DESOGESTREL IMPURITY D; 18,19-Dinorpregn-4-en-20-yn-3-one,13-ethyl-17-hydroxy-11-methylene-, (17a)-; (1R,3aS,3bS,9aR,9bS,11aS)-11a-ethyl-1-ethynyl-1-hydroxy-10-methylidene-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one; Implanon (TN); (8S,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-11-methylene-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one; Desogestrel EP Impurity D; Etonogestrel (USAN/INN); UNII-304GTH6RNH; Etonogestrel [USAN:INN:BAN]; Nexplanon (TN); NCGC00168777-01; 13-Ethyl-17-hydroxy-11-methylidene-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one (3-Ketodesogestrel); EINECS 258-936-2; Etonogestrel Impurity 9; 17-Ethinyl-17-beta-hydroxy-18-methyl-11-methylene-4-estren-3-one; ETONOGESTREL [MI]; ETONOGESTREL [INN]; ETONOGESTREL [USAN]; (17alpha)-13-Ethyl-17-hydroxy-11-methylene-18,19-dinorpregn-4-en-20-yn-3-one; CHEMBL1531; Etonogestrel [EP monograph]; ETONOGESTREL [VANDF]; ETONOGESTREL [MART.]; ETONOGESTREL [USP-RS]; ETONOGESTREL [WHO-DD]; SCHEMBL117703; GTPL7590; orb1305313; orb1941033; Etonogestrel, >=98% (HPLC); ETONOGESTREL [ORANGE BOOK]; GLXC-90547; HY-B0652; MSK14464; Tox21_112638; BDBM50423516; EBC-26587; s4673; NUVARING COMPONENT ETONOGESTREL; 13-Ethyl-11-methylene-18,19-dinor-17-alpha-pregn-4-en-20-yn-3-one; 17alpha-ethynyl-17beta-hydroxy-11-methylidene-18a-homo-estr-4-en-3-one; AKOS030526156; CCG-267753; DB00294; FE23201; NCGC00168777-04; (8S,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-11-methylene-2,6,7,8,9,10,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one; AS-73246; SY465228; CAS-54048-10-1; DESOGESTREL IMPURITY D [EP IMPURITY]; NS00006394; C75537; D04104; EN300-19767790; F826236; Q3733839; Etonogestrel, United States Pharmacopeia (USP) Reference Standard; (17a)-13-ethyl-17-hydroxy-11-methylene-18,19-dinorpregn-4-en-20-yn-3-one; 13-Ethyl-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-17-ol-3-one; (1R,3aS,3bS,9aR,9bS,11aS)-11a-Ethyl-1-ethynyl-1-hydroxy-10-methylidene-1,2,3,3a,3b,4,5,8,9,9a,9b,10,11,11a-tetradecahydro-7H-cyclopenta[a]phenanthren-7-one; (8S,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-11-methylene-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one; 13-Ethyl-17-ethynyl-17-h ydroxy-11-methylidene-2,6,7,8,9,10,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-one; 18,19-DINOR-17.ALPHA.-PREGN-4-EN-20-YN-3-ONE, 13-ETHYL-17-HYDROXY-11-METHYLENE-別名